Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli
Authors:
- 28 December 2011
- journal article
- biotechnologically relevant-enzymes-and-proteins
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 95 (4) , 939-945
Abstract
The housefly (Musca domestica) larvae have been used clinically to cure osteomyelitis, decubital necrosis, lip boil, ecthyma and malnutritional stagnation ever since the Ming/Qing Dynasty (1368 Anno Domini) till now, in China. In prior research, we have cloned and characterized a new gene of antimicrobial peptide cecropin from M. domestica larvae. This peptide was potently active against Gram-positive and Gram-negative bacteria standard strain. In the present study, we evaluated the possibility of Mdc to be a potential bactericidal agent against clinical isolates of multidrug-resistant (MDR) Escherichia coli and to elucidate the related antimicrobial mechanisms. Antimicrobial activity assays indicated a minimal inhibitory concentration (MIC) of 1.56 μM. Bactericidal kinetics at MIC showed that Mdc rapid killing of MDR E. coli. Lipopolysaccharide (LPS) dose-dependently suppressed Mdc antibacterial potency indicates that LPS is the initial binding site of Mdc in E. coli. Propidium iodide-based flow cytometry revealed that Mdc causes E. coli membrane permeabilization. Transmission electron micrographs further indicated that a remarkable damage in the bacteria’s outer and inner membrane, even the leakage of cytoplasmic contents induced by Mdc. DNA binding experimental result implies that DNA is one of the possible intracellular targets of Mdc. Of note, Mdc did not show a perceptible cytotoxic effect on human red blood cells. Altogether, these results suggest that Mdc could be an excellent candidate for the development of more efficacious bactericidal agents.Keywords
This publication has 19 references indexed in Scilit:
- Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 againstEscherichia coliandProteus mirabilisBiochemical Journal, 2010
- Antimicrobial peptides: General overview and clinical implications in human health and diseaseClinical Immunology, 2010
- Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosaInnate Immunity, 2009
- Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27Applied Microbiology and Biotechnology, 2009
- Membrane permeability and antimicrobial kinetics of cecropin P1 against Escherichia coliJournal of Peptide Science, 2009
- Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patientsJournal of Translational Medicine, 2009
- Escherichia coli expression and purification of four antimicrobial peptides fused to a family 3 carbohydrate-binding module (CBM) from Clostridium thermocellumProtein Expression and Purification, 2008
- Antibacterial activity and in vitro anti-tumor activity of the extract of the larvae of the housefly (Musca domestica)Journal of Ethnopharmacology, 2007
- Current Guidelines for the Treatment of Severe Pneumonia and SepsisChemotherapy, 2005
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005